Clinical Trial Update: Examining Effects of Intrarosa in Women With Genitourinary Syndrome of Menopause/Vulvovaginal Atrophy [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating Intrarosa in women with genitourinary syndrome of menopause and vulvovaginal atrophy; the current status of the study is unknown…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyspareunia
• Genitourinary Syndrome of Menopause
• Menopause
• Vulvovaginal Atrophy

Drugs mentioned

• Intrarosa (prasterone)

Snippet

Sponsor: Center for Vulvovaginal Disorders | Conditions: Menopause, Genitourinary Syndrome of Menopause | Phase 3 | Status: UNKNOWN